Can Dual Long-Acting Bronchodilator Therapy Prevent Clinically Important Deteriorations In Chronic Obstructive Pulmonary Disease? A Post Hoc Analysis Of The Zep117115 Trial

被引：0
|
作者：
Singh, D. [1 ]
Maleki-Yazdi, M. [2 ]
Tombs, L. [3 ]
Naya, I. [3 ]
Church, A. [4 ]
Iqbal, A. [4 ]
机构：
[1] Univ Manchester, Med Evaluat Unit, Univ Hosp South Manchester NHS Fdn Trust, Manchester, Lancs, England
[2] Univ Toronto, Womens Coll Hosp, Div Resp Med, Toronto, ON, Canada
[3] GlaxoSmithKline, Stockley Pk, England
[4] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5760
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease
    Yuasa, Mizuki
    Tanaka, Yosuke
    Tanaka, Tohru
    Kashiwada, Takeru
    Taniuchi, Namiko
    Saito, Yoshinobu
    Seike, Masahiro
    Hino, Mitsunori
    Gemma, Akihiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [42] Long-Acting β-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial
    Celli, Bartolome
    Anderson, Julie A.
    Brook, Robert
    Calverley, Peter
    Crim, Courtney
    Holmes, Andrew P.
    Martinez, Fernando J.
    Newby, David E.
    Yates, Julie
    Vestbo, Jorgen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (12) : 1641 - 1644
  • [43] COMPARISON OF MONOTHERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST VERSUS COMBINATION THERAPY WITH A LONG-ACTING MUSCARINIC ANTAGONIST PLUS A LONG-ACTING BETA2-AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Yosuke, Tanaka
    Mitsunori, Hino
    Naomi, Onda
    Hiroyuki, Takoi
    Seiji, Kosaihira
    Norihisa, Motohashi
    Akihiko, Gemma
    RESPIROLOGY, 2014, 19 : 122 - 122
  • [44] Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
    DiSantostefano, Rachael L.
    Sampson, Tim
    Hoa Van Le
    Hinds, David
    Davis, Kourtney J.
    Bakerly, Nawar Diar
    PLOS ONE, 2014, 9 (05):
  • [45] Bronchodilating long-acting drugs in the treatment of stable chronic obstructive pulmonary disease. Analysis of the latest data
    Stepanyan, I. E.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (11) : 92 - 95
  • [46] Combination therapy of inhaled corticosteroids and long-acting β2-adrenergics in management of patients with chronic obstructive pulmonary disease
    Sin, DD
    Johnson, M
    Gan, WQ
    Man, SFP
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (28) : 3547 - 3560
  • [47] Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
    Kalberg C.
    O’Dell D.
    Galkin D.
    Newlands A.
    Fahy W.A.
    Drugs in R&D, 2016, 16 (2) : 217 - 227
  • [48] Preventing Clinically Important Deterioration with Umeclidinium/Vilanterol Versus Bronchodilator Monotherapy in Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: A Prospective Analysis of the EMAX Trial
    Vogelmeier, C.
    Maltais, F.
    Kerwin, E.
    Bjermer, L.
    Naya, I.
    Tombs, L.
    Boucot, I.
    Watkins, M. L.
    Lipson, D. A.
    Compton, C.
    Jones, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting I32-Agonist Dual Therapy in a Primary Care Setting in England
    Requena, Gema
    Banks, Victoria
    Czira, Alexandrosz
    Wood, Robert
    Tritton, Theo
    Wild, Rosie
    Compton, Chris
    Duarte, Maria
    Ismaila, Afisi S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1781 - 1795
  • [50] Inhaled Corticosteroid Plus Long-Acting β2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies
    Watz, H.
    Ferguson, G. T.
    Gronke, L.
    Vob, F.
    Abrahams, R.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345